Research & Development



  “有道理,這一副竹牌本官就不客氣了。”   霍去病皺眉道︰“有辦法?”大香蕉网站   雲瑯走進來瞅著剩余的十四個護衛對長平道︰“喝完了,他的身體很弱,至少要在這里待半年。”中文字幕大香蕉在线   等雲瑯謄抄好《百工譜》之後,已經是三天之後了。   雲瑯連忙點點頭。青青草AV在线视频观免   “說了,一字不漏,對了,忘了問你,你怎麼跟去病,李敢三人睡一張床啊?”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo